Silexion Therapeutics Corp
SLXNNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for SLXN. That does not mean none is planned.
Get an email about SLXN's next catalysts
Track Silexion Therapeutics (SLXN) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
SLXN Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
No drugs found in this phase.
Frequently asked questions
When is Silexion Therapeutics Corp's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Silexion Therapeutics Corp (SLXN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track SLXN biotech catalysts?→
Add SLXN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Silexion Therapeutics Corp's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.